This session covers two growing areas where expanding pharmacy services is needed: the emergency department (ED) and use of biosimilars. Both clinical and operational issues that should be considered when establishing pharmacy services in the ED are reviewed. Clinical best practices will be shared to help pharmacy clinicians better understand the scope and role that pharmacists can play to help improve patient care and overall patient outcomes. The variability in using recent research and practice guidelines as well as ways to better use evidence-based practices will be discussed. Clinical and operational issues associated with the oversight of safe and appropriate use of non-oncologic biopharmaceuticals, including biosimilars will be addressed. Clinical best practices involving biosimilars are shared. Presenters will interact with participants in several ways including polling questions and direct question/answer segments.
At the completion of this activity, participants will be able to: